India to Brazil: Citalopram Export Trade Route
India has recorded 230 verified shipments of Citalopram exported to Brazil, representing a combined trade value of $10.7M USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $46.6K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED , which accounts for 48% of total export value with 54 shipments worth $5.1M USD. On the buying side, M/S. RANBAXY FARMACEUTICA LTDA : is the largest importer in Brazil with $3.9M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED , SANDOZ PRIVATE LIMITED, SANDOZ PRIVATE LIMITED — together control 77% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Citalopram corridor is one of India's established pharmaceutical export routes, with 230 shipments documented worth a combined $10.7M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED , which alone accounts for roughly 48% of all export value, reflecting the consolidated nature of India's citalopram manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $46.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with citalopram's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 16.8%, placing it at rank #11 among India's top citalopram export destinations globally.
On the import side, key buyers of Indian citalopram in Brazil include M/S. RANBAXY FARMACEUTICA LTDA : , M/S. RANBAXYFARMACEUTICA LTDA , SANDOZ DO BRASIL IND FARMACEUTICA and 21 others. M/S. RANBAXY FARMACEUTICA LTDA : is the single largest importer with 40 shipments valued at $3.9M USD.
Route Characteristics
- Average transit32 days
- Peak seasonQ1
- Primary modeSea freight
- Top portDHANNAD ICD (INDHA6)
Market Position
- Global rank#11
- Annual growth+16.8%
- Demand growth+16.4%
- Regulatory ease83/100
Top 10 Indian Citalopram Exporters to Brazil
Showing top 10 of 11 Indian suppliers exporting Citalopram to Brazil, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $95.0K per shipment | 54 | $5.1M | 47.9% |
| 2 | SANDOZ PRIVATE LIMITED Avg $74.4K per shipment | 21 | $1.6M | 14.6% |
| 3 | SANDOZ PRIVATE LIMITED Avg $102.7K per shipment | 15 | $1.5M | 14.4% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $12.1K per shipment | 54 | $652.2K | 6.1% |
| 5 | TORRENT PHARMACEUTICALS LTD Avg $32.9K per shipment | 19 | $625.2K | 5.8% |
| 6 | TORRENT PHARMACEUTICALS LTD Avg $13.9K per shipment | 34 | $471.4K | 4.4% |
| 7 | TORRENT PHARMACEUTICALS LIMITED Avg $17.9K per shipment | 22 | $394.5K | 3.7% |
| 8 | ZYDUS LIFESCIENCES LIMITED Avg $34.9K per shipment | 4 | $139.7K | 1.3% |
| 9 | ZYDUS LIFESCIENCES LIMITED Avg $29.1K per shipment | 4 | $116.3K | 1.1% |
| 10 | CADILA HEALTHCARE LIMITED Avg $21.1K per shipment | 2 | $42.1K | 0.4% |
This table shows the top 10 of 11 Indian companies exporting citalopram to Brazil, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED , SANDOZ PRIVATE LIMITED, SANDOZ PRIVATE LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED, TORRENT PHARMACEUTICALS LTD , TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LIMITED, ZYDUS LIFESCIENCES LIMITED, ZYDUS LIFESCIENCES LIMITED , CADILA HEALTHCARE LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 54 shipments worth $5.1M USD, giving it a 48% market share. The top 3 suppliers together account for 77% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to Brazil Citalopram export route.
Top 10 Citalopram Importers in Brazil
Showing top 10 of 24 known buyers in Brazil receiving Citalopram shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian citalopram in Brazil include M/S. RANBAXY FARMACEUTICA LTDA : , M/S. RANBAXYFARMACEUTICA LTDA , SANDOZ DO BRASIL IND FARMACEUTICA, SANDOZ DO BRASIL IND FARMACEUTICA , SANDOZ DO BRASIL IND FARMAC?UTICA , among 24 total buyers. The largest importer is M/S. RANBAXY FARMACEUTICA LTDA : , accounting for $3.9M USD across 40 shipments — representing 37% of all citalopram imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | M/S. RANBAXY FARMACEUTICA LTDA : | 40 | $3.9M | 36.9% |
| 2 | M/S. RANBAXYFARMACEUTICA LTDA | 7 | $1.0M | 9.6% |
| 3 | SANDOZ DO BRASIL IND FARMACEUTICA | 12 | $904.8K | 8.4% |
| 4 | SANDOZ DO BRASIL IND FARMACEUTICA | 8 | $875.3K | 8.2% |
| 5 | SANDOZ DO BRASIL IND FARMAC?UTICA | 7 | $664.9K | 6.2% |
| 6 | TORRENT DO BRASIL LTDA | 40 | $646.4K | 6.0% |
| 7 | TORRENT DO BRASIL LTDA | 18 | $625.1K | 5.8% |
| 8 | M/S. RANBAXY FARMACEUTICA LTDA : | 31 | $507.2K | 4.7% |
| 9 | SANDOZ DO BRASIL IND FARMACEUTICA RUA ANTONIO RASTEIRO | 3 | $361.6K | 3.4% |
| 10 | SANDOZ DO BRASIL IND FARMAC?UTICA | 6 | $296.2K | 2.8% |
Showing top 10 of 24 Citalopram importers in Brazil on this route.
Top 10 Citalopram Formulations Imported by Brazil
Showing top 10 of 134 product formulations shipped on the India to Brazil Citalopram route, ranked by trade value
Brazil imports a wide range of citalopram formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CITALOPRAM TAB 20MG PACK:BOX30s BATCH:DF — accounts for $2.2M USD across 13 shipments. There are 134 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CITALOPRAM TAB 20MG PACK:BOX30s BATCH:DF | 13 | $2.2M | 20.7% |
| 2 | CITALOPRAM TAB 20MG PACK:BOX30s BATCH: | 7 | $1.3M | 12.2% |
| 3 | Material No. - 42030715, ESCITALOPRAM OX | 3 | $441.1K | 4.1% |
| 4 | Material No-42030715, ESCITALOPRAM OXA F | 2 | $333.5K | 3.1% |
| 5 | Material No - 42030715, ESCITALOPRAM OXA | 2 | $333.5K | 3.1% |
| 6 | ESCITALOPRAM OXALATE TABLETS 10MG PACK: | 5 | $297.8K | 2.8% |
| 7 | CITALOPRAM TAB 20MG PACK:BOX 30s BATCH: | 1 | $272.7K | 2.5% |
| 8 | Material No.-42030715 ESCITALOPRAM OXAFCT 20MG IN91 SH MS BATCH NO.NH4516 NH4190NH4187NH4195NH4194NH3532 MANUFACTURING DATE | 1 | $254.3K | 2.4% |
| 9 | Material No 42030721 ESCITALOPRAM OXAFCT 10MG IN91 SH MS BATCH NO MV2415 MV2420 MV2417 MFG DATE 15 02 2023 DA | 2 | $242.2K | 2.3% |
| 10 | ESCITALOPRAM OXAL TAB 10MG PACK:BOX3X10s | 5 | $217.7K | 2.0% |
Showing top 10 of 134 Citalopram formulations imported by Brazil on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DHANNAD ICD (INDHA6) handles the highest volume with 57 shipments. Transit time averages 32 days by sea.
Market Dynamics
India's citalopram exports to Brazil are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 54 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED , SANDOZ PRIVATE LIMITED, SANDOZ PRIVATE LIMITED — together account for 77% of total trade value on this route. The average shipment value of $46.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as citalopram tab 20mg pack:box30s batch: and material no. - 42030715, escitalopram ox , suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, M/S. RANBAXY FARMACEUTICA LTDA : is the largest importer with 40 shipments worth $3.9M USD — representing 37% of all citalopram imports from India on this route. A total of 24 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $10.7M
- Avg. Shipment
- $46.6K
- Suppliers
- 11
- Buyers
- 24
- Transit (Sea)
- ~32 days
- Annual Growth
- +16.8%
Related Analysis
Reverse Direction
Brazil → India — Citalopram (Import)Other Citalopram Routes
Unlock the Full India to Brazil Citalopram Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 230 shipments on this route.
Frequently Asked Questions — India to Brazil Citalopram Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Citalopram to Brazil?
The leading Indian exporters of Citalopram to Brazil are SUN PHARMACEUTICAL INDUSTRIES LIMITED , SANDOZ PRIVATE LIMITED, SANDOZ PRIVATE LIMITED . SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 48% of total trade value on this route.
Q What is the total value of Citalopram exports from India to Brazil?
India exports Citalopram to Brazil worth approximately $10.7M USD across 230 recorded shipments. The average value per shipment is $46.6K USD.
Q Which ports does India use to ship Citalopram to Brazil?
The most active port of origin is DHANNAD ICD (INDHA6) with 57 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to Brazil for Citalopram?
The average transit time for Citalopram shipments from India to Brazil is approximately 32 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Brazil Citalopram trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 16.8% with demand growth tracking at 16.4%. The route is ranked #11 among India's top Citalopram export destinations globally.
Q How many suppliers are active on the India to Brazil Citalopram route?
There are currently 11 active Indian suppliers exporting Citalopram to Brazil. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 48% of total shipment value.
Q Who are the main importers of Citalopram from India in Brazil?
The leading importers of Indian Citalopram in Brazil include M/S. RANBAXY FARMACEUTICA LTDA : , M/S. RANBAXYFARMACEUTICA LTDA , SANDOZ DO BRASIL IND FARMACEUTICA, SANDOZ DO BRASIL IND FARMACEUTICA , SANDOZ DO BRASIL IND FARMAC?UTICA . M/S. RANBAXY FARMACEUTICA LTDA : is the largest buyer with 40 shipments worth $3.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Brazil export trade corridor identified from Indian Customs (DGFT) records for Citalopram.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 24 importers in Brazil matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 230 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
230 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists